Farida Abane

Farida Abane, MD has a diverse work experience in the field of pharmacovigilance and drug safety. Farida is currently serving as the Senior Medical Director, Pharmacovigilance at Deciphera Pharmaceuticals since June 2022. Prior to this, they held the position of Medical Director, Pharmacovigilance at the same company from August 2020 to June 2022 and was an Associate Medical Director, Pharmacovigilance from June 2019 to August 2020.

Before joining Deciphera, Farida worked as a Clinical Safety Reviewer at Cardiovascular Research Foundation from October 2017 to June 2019. In this role, they had responsibilities such as tracking adverse events, ensuring compliance with health authorities' requirements, and facilitating the safety reporting process.

Farida also has experience in Clinical Trial Management at Sollers from April 2017 to September 2017. Additionally, Farida worked as a Medical Review Physician at Hays from July 2014 to March 2016, where they performed medical reviews of adverse events and conducted signal detection activities.

Farida's earlier experiences include positions as a Medical Review Physician at Universal Pharma from September 2013 to June 2014, where they conducted medical reviews and prepared aggregate safety reports, and as a Drug Safety Officer at Stallergenes Greer from May 2008 to July 2013. In this role, they completed medical assessments and responded to various inquiries related to adverse drug reactions.

Farida'scareer in pharmacovigilance started with a Pharmacovigilance diploma at For Drug Consulting in March 2008.

Farida Abane, MD, has a Doctor of Medicine (MD) degree in General Medicine from Medical school (Algeria), which they completed from 1992 to 2000. Farida also holds a Medical Specialty Diploma in Gynaecology and Obstetrics, which they obtained from the same medical school from 2001 to 2006. In 2003 to 2004, they completed an Obstetrics and Gynecology Residency Program at the Mutualist Montsouris Institute in Paris, France. In 2008, they received a Pharmacovigilance Certification from FOR DRUG CONSULTING SCHOOL. In 2013, they completed a course on electronic submission of Individual Case Safety Reports (ICSRs) at EMA. Finally, in 2017, they obtained a Certificate in Clinical Trial Management from Sollers Institute in Edison, New Jersey, USA.